Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Kaplan-Meier Survival Analysis: Practical Insights for CliniciansActa médica portuguesa, 2024-04, Vol.37 (4)ISSN: 0870-399X ;EISSN: 1646-0758 ;DOI: 10.20344/amp.21080Full text available |
|
2 |
Material Type: Article
|
Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized TrialJournal of clinical oncology, 2020-09, Vol.38 (25), p.2830-2838 [Peer Reviewed Journal]2020 by American Society of Clinical Oncology 2020 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.20.00818 ;PMID: 32484754Full text available |
|
3 |
Material Type: Article
|
Dexamethasone in Hospitalized Patients with Covid-19New England Journal of Medicine, 2021-02, Vol.384 (8), p.693-704 [Peer Reviewed Journal]Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2021436 ;PMID: 32678530Digital Resources/Online E-Resources |
|
4 |
Material Type: Article
|
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome AnalyticsCell, 2018-04, Vol.173 (2), p.400-416.e11 [Peer Reviewed Journal]2018 Elsevier Inc. ;Copyright © 2018 Elsevier Inc. All rights reserved. ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2018.02.052 ;PMID: 29625055Full text available |
|
5 |
Material Type: Article
|
Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancerClinical cancer research, 2015-04, Vol.21 (7), p.1688-1698 [Peer Reviewed Journal]2014 American Association for Cancer Research. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.ccr-14-0432 ;PMID: 25208879Full text available |
|
6 |
Material Type: Article
|
Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS TrialJournal of clinical oncology, 2021-06, Vol.39 (18), p.1995-2004 [Peer Reviewed Journal]ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.20.03614 ;PMID: 33891478Full text available |
|
7 |
Material Type: Article
|
QuPath: Open source software for digital pathology image analysisScientific reports, 2017-12, Vol.7 (1), p.16878-7, Article 16878 [Peer Reviewed Journal]2017. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2017 ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-017-17204-5 ;PMID: 29203879Full text available |
|
8 |
Material Type: Article
|
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival AnalysesNeoplasia (New York, N.Y.), 2017-08, Vol.19 (8), p.649-658 [Peer Reviewed Journal]2017 The Authors ;Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved. ;Copyright Neoplasia Press Aug 2017 ;ISSN: 1476-5586 ;ISSN: 1522-8002 ;EISSN: 1476-5586 ;DOI: 10.1016/j.neo.2017.05.002 ;PMID: 28732212Full text available |
|
9 |
Material Type: Article
|
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trialThe Lancet (British edition), 2008-09, Vol.372 (9644), p.1174-1183 [Peer Reviewed Journal]Elsevier Ltd ;2008 Elsevier Ltd ;Copyright Elsevier Limited Sep 27-Oct 3, 2008 ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(08)61242-8 ;PMID: 18757085 ;CODEN: LANCAOFull text available |
|
10 |
Material Type: Article
|
Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057)Journal of clinical oncology, 2017-12, Vol.35 (35), p.3924-3933 [Peer Reviewed Journal]2017 by American Society of Clinical Oncology 2017 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2017.74.3062 ;PMID: 29023213Full text available |
|
11 |
Material Type: Article
|
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination SettingNew England Journal of Medicine, 2021-04, Vol.384 (15), p.1412-1423 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2101765 ;PMID: 33626250Digital Resources/Online E-Resources |
|
12 |
Material Type: Article
|
Predicting Survival in Patients With Pulmonary Arterial Hypertension: The REVEAL Risk Score Calculator 2.0 and Comparison With ESC/ERS-Based Risk Assessment StrategiesChest, 2019-08, Vol.156 (2), p.323-337 [Peer Reviewed Journal]Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved. ;EISSN: 1931-3543 ;DOI: 10.1016/j.chest.2019.02.004 ;PMID: 30772387Full text available |
|
13 |
Material Type: Article
|
Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial ResultsNew England Journal of Medicine, 2021-02, Vol.384 (6), p.497-511 [Peer Reviewed Journal]Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Distributed under a Creative Commons Attribution 4.0 International License ;Copyright © 2020 Massachusetts Medical Society. All rights reserved. 2020 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2023184 ;PMID: 33264556Digital Resources/Online E-Resources |
|
14 |
Material Type: Article
|
A Fully Magnetically Levitated Left Ventricular Assist Device — Final ReportThe New England journal of medicine, 2019-04, Vol.380 (17), p.1618-1627 [Peer Reviewed Journal]Copyright © 2019 Massachusetts Medical Society. All rights reserved. ;Copyright © 2019 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1900486 ;PMID: 30883052Full text available |
|
15 |
Material Type: Article
|
Cryoballoon or Radiofrequency Ablation for Paroxysmal Atrial FibrillationThe New England journal of medicine, 2016-06, Vol.374 (23), p.2235-2245 [Peer Reviewed Journal]Copyright © 2016 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1602014 ;PMID: 27042964Full text available |
|
16 |
Material Type: Article
|
ARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate CancerJournal of clinical oncology, 2019-11, Vol.37 (32), p.2974-2986 [Peer Reviewed Journal]2019 by American Society of Clinical Oncology 2019 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.19.00799 ;PMID: 31329516Full text available |
|
17 |
Material Type: Article
|
The single-cell pathology landscape of breast cancerNature (London), 2020-02, Vol.578 (7796), p.615-620 [Peer Reviewed Journal]COPYRIGHT 2020 Nature Publishing Group ;COPYRIGHT 2020 Nature Publishing Group ;Copyright Nature Publishing Group Feb 27, 2020 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-019-1876-x ;PMID: 31959985Full text available |
|
18 |
Material Type: Article
|
Venetoclax plus LDAC for newly diagnosed AML ineligible for intensive chemotherapy: a phase 3 randomized placebo-controlled trialBlood, 2020-06, Vol.135 (24), p.2137-2145 [Peer Reviewed Journal]2020 American Society of Hematology ;2020 by The American Society of Hematology. ;2020 by The American Society of Hematology 2020 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2020004856 ;PMID: 32219442Full text available |
|
19 |
Material Type: Article
|
Initial Invasive or Conservative Strategy for Stable Coronary DiseaseThe New England journal of medicine, 2020-04, Vol.382 (15), p.1395-1407 [Peer Reviewed Journal]Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1915922 ;PMID: 32227755Full text available |
|
20 |
Material Type: Article
|
DeepSurv: personalized treatment recommender system using a Cox proportional hazards deep neural networkBMC medical research methodology, 2018-02, Vol.18 (1), p.24-24, Article 24 [Peer Reviewed Journal]COPYRIGHT 2018 BioMed Central Ltd. ;The Author(s) 2018 ;ISSN: 1471-2288 ;EISSN: 1471-2288 ;DOI: 10.1186/s12874-018-0482-1 ;PMID: 29482517Full text available |